Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Aquestive Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- −1 vs. Q3 2024
- Shares held
- 43.4M
- −3.27M (−7.0%) vs. Q3 2024
- Total value
- $154.4M
- −$77.4M (−33.4%) vs. Q3 2024
- New holders
- 21
- 46 more added
- Sold out
- 22
- 33 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AQST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $299.5M |
| Q1 2026 | 180 | $298.6M |
| Q4 2025 | 179 | $467.0M |
| Q3 2025 | 152 | $369.3M |
| Q2 2025 | 117 | $157.6M |
| Q1 2025 | 121 | $127.8M |
| Q4 2024 | 114 | $154.4M |
| Q3 2024 | 117 | $232.4M |
| Q2 2024 | 98 | $110.7M |
| Q1 2024 | 97 | $176.8M |
| Q4 2023 | 57 | $48.1M |
| Q3 2023 | 48 | $21.5M |
| Q2 2023 | 54 | $31.5M |
| Q1 2023 | 35 | $17.0M |
| Q4 2022 | 37 | $13.5M |
| Q3 2022 | 46 | $18.6M |
| Q2 2022 | 46 | $10.7M |
| Q1 2022 | 51 | $40.6M |
| Q4 2021 | 52 | $62.9M |
| Q3 2021 | 46 | $64.4M |
| Q2 2021 | 60 | $62.0M |
| Q1 2021 | 64 | $86.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Aquestive Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Essex Investment Management Co LLC | 623,310 | $2.22M | 0.40% | −83,768−11.8% | Reduced |
| Bank of America Corp | 690,284 | $2.46M | 0.00% | +621,614+905.2% | Added |
| Morgan Stanley | 736,889 | $2.62M | 0.00% | +65,400+9.7% | Added |
| Goldman Sachs Group Inc | 876,537 | $3.12M | 0.00% | +653,850+293.6% | Added |
| Blue Owl Capital Holdings LP | 900,000 | $3.20M | 0.76% | −325,000−26.5% | Reduced |
| Janney Montgomery Scott LLC | 984,485 | $3.50M | 0.01% | +61,200+6.6% | Added |
| State Street Corp | 1,503,891 | $5.35M | 0.00% | +7,152+0.5% | Added |
| MPM Oncology Impact Management LP | 1,611,833 | $5.74M | 0.81% | −184,917−10.3% | Reduced |
| Geode Capital Management, LLC | 1,654,596 | $5.89M | 0.00% | −12,919−0.8% | Reduced |
| Franklin Resources Inc | 2,134,796 | $7.60M | 0.00% | −631,746−22.8% | Reduced |
| VR Adviser, LLC | 2,629,786 | $9.36M | 0.64% | −2,925,769−52.7% | Reduced |
| Vanguard Group Inc | 4,346,754 | $15.5M | 0.00% | +82,958+1.9% | Added |
| BlackRock, Inc. | 5,998,598 | $21.4M | 0.00% | +175,521+3.0% | Added |
| Bratton Capital Management, L.P. | 9,810,958 | $34.9M | 100.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −199,729−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −192,856−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −155,145−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −137,151−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −85,392−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −28,937−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −27,198−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,986−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −22,046−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −19,700−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −14,493−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −14,475−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −10,073−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −5,700−100.0% | Sold out |
| Torno Capital, LLC | 0 | $0 | 0.00% | −4,200−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −119−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −19,920−100.0% | Sold out |
| Chartwell Investment Partners, LLC | – | – | – | – | Not filed |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |